Source: ERS Lung Science Conference 2021
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Victoria Ptasinski, Sweden. PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids. ERS Lung Science Conference 2021

Member's Comments

No comment yet.

Related content which might interest you: LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Engineering distal pulmonary epithelium from induced pluripotent stem cell (iPSC)-derived alveolar cells Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 205-221 Year: 2021 Using induced pluripotent stem cells to model the human lung alveolar epithelium Source: International Congress 2018 – Pathophysiology of the human lung alveolus Year: 2018 PP238 – Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis Source: ERS Lung Science Conference 2021 Year: 2021 Pulmonary transplantation of human induced pluripotent stem cell-derived macrophages Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside Year: 2019 Induced pluripotent stem cell-derived alveolar epithelial cells: applications with lung-on-a-chip Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside Year: 2019 Epithelial stem cells at the intersection of tissue regeneration and pulmonary fibrosis Source: Eur Respir Monogr 2021; 91: 290-305 Year: 2021 Mechanical programming of mesenchymal stromal cells to treat lung fibrosis Source: ERS Lung Science Conference 2018 Year: 2018 Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 190-204 Year: 2021 Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Pulmonary interstitial glycogenosis cells express mesenchymal stem cell markers Source: Eur Respir J, 56 (4) 2000853; 10.1183/13993003.00853-2020 Year: 2020 Pulmonary fibrosis modulation by mesenchymal stem cells and conditioned medium Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Use of alveolar epithelial cells derived from induced pluripotent stem cell to study alveolar wound repair in vitro Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 The secretome of induced pluripotent stem cells (iPSC) modulates macrophage phenotype in the fibrotic lung Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Lineage differentiation of pulmonary alveolar fibroblasts Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 Pluripotent stem cells isolated from adult human lung tissue exhibit anti-fibrotic properties Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 Derivation of epithelial-only airway organoids from human pluripotent stem cells Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside Year: 2019